We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INNL
76
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.22M 0.21%
547,792
-12,208
-2% -$69.1K
AVEO
77
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.77M 0.18%
310,881
– –
ISEE
78
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.74M 0.18%
+600,000
New +$33.8M
APVO icon
79
Aptevo Therapeutics
APVO
$3.1M
– –
0
– –
TARA icon
80
Protara Therapeutics
TARA
$222M
$2.51M 0.16%
6,725
-150
-2% -$52.8K
MGCD
81
DELISTED
MGC Diagnostics Corporation
MGCD
$2.27M 0.15%
329,733
-6,554
-2% -$45.3K
NEOS
82
DELISTED
Neos Therapeutics, Inc
NEOS
$2.17M 0.14%
330,593
-296,283
-47% -$2.35M
RXDX
83
DELISTED
Ignyta, Inc.
RXDX
$2.14M 0.14%
339,727
-95,533
-22% -$555K
ACAD icon
84
Acadia Pharmaceuticals
ACAD
$4.61B
$2.08M 0.13%
65,240
-100,000
-61% -$3.39M
AFMD
85
DELISTED
Affimed
AFMD
$2.04M 0.13%
73,430
– –
ABT icon
86
Abbott
ABT
$177B
$1.95M 0.13%
46,019
+42,979
+1,414% +$1.84M
EIGR
87
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.74M 0.11%
4,331
+834
+24% +$426K
CBPO
88
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$1.71M 0.11%
13,695
-305
-2% -$36K
BIO icon
89
Bio-Rad Laboratories Class A
BIO
$10.1B
$1.64M 0.11%
+10,000
New +$1.52M
GNMX
90
DELISTED
Aevi Genomic Medicine Inc
GNMX
$1.64M 0.11%
293,460
-6,540
-2% -$37.3K
VCRA
91
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.59M 0.1%
+94,236
New +$1.44M
ADYX
92
DELISTED
Adynxx Inc
ADYX
$1.54M 0.1%
32,033
– –
VCEL icon
93
Vericel Corp
VCEL
$2.03B
$1.53M 0.1%
544,996
-12,346
-2% -$28.5K
NVRO
94
DELISTED
NEVRO CORP.
NVRO
$1.23M 0.08%
11,746
-353,483
-97% -$31.9M
ALPN
95
DELISTED
Alpine Immune Sciences Inc
ALPN
$994K 0.06%
30,569
-681
-2% -$16.6K
ATRS
96
DELISTED
Antares Pharma, Inc.
ATRS
– –
0
– –
ONSIZ
97
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$787K 0.05%
656,382
+193,882
+42% +$141K
ANIP icon
98
ANI Pharmaceuticals
ANIP
$1.66B
$767K 0.05%
11,561
-55,600
-83% -$3.48M
LCI
99
DELISTED
Lannett Company, Inc.
LCI
$709K 0.05%
6,668
– –
SYRE icon
100
Spyre Therapeutics
SYRE
$8.02B
$664K 0.04%
4,143
-93
-2% -$12.9K
2 3
4
5 6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.